secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001193125-23-149296
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Pieris receives Nasdaq bid-price deficiency notice; 180-day cure period
-----------------------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive business days triggers deficiency under Nasdaq Listing Rule 5550(a)(2).
- Company has until November 13, 2023 to regain compliance; needs $1.00+ close for 10 consecutive days.
- If not cured by initial date, may be eligible for additional 180-day period if other listing standards are met.
- Options being considered include a reverse stock split; no immediate effect on trading under symbol PIRS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000119312523149296/0001193125-23-149296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000119312523149296/d448653d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-149296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer